China Clears Swiss-Based Novartis For Largest Buy Of Local Firm
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities have given Novartis of Switzerland clearance to go ahead ith its acquisition of Zhejiang Tianyuan Bio-Pharmaceutical, one of China's leading makers of vaccines